Axitan

Axitan is a biotech company focused on eliminating antibiotics from animal feed and improving productivity. It is developing a library of endolysins capable of targeting those pathogens that impact livestock farming historically managed through antibiotic supplements in animal feed. Its focus forms part of wider WHO One Health initiative to combat the threat posed by antimicrobial resistance caused by the overuse of antibiotics, animals accounting for the majority (66%) of the antibiotics consumed globally each year. In October 2022, Axitan achieved US FDA GRAS (“Generally Recognised As Safe”) affirmation for the algal biomass ingredient used in its first product, FORC3®, which promotes healthy growth in poultry by targeting Clostridium perfringens. Axitan has operations in the UK and US. Further information on the Company and FORC3® can be found at www.axitan.com